Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack Cuzick

Showing results (21-30 of 420) with videos related to

Pageof 42
Sort By:
Expert Review of Anticancer Therapy|November 22, 2007
The ATAC trial: the vanguard trial for use of aromatase inhibitors in early breast cancerJack Cuzick
Expert Review of Anticancer Therapy|September 2, 2008
IBIS II: a breast cancer prevention trial in postmenopausal women using the aromatase inhibitor anastrozoleJack Cuzick
Journal of the National Cancer Institute|June 18, 2010
Tamoxifen and the factor V Leiden mutationJack Cuzick
Journal of the National Cancer Institute|November 9, 2014
Endpoints for the evaluation of breast cancer treatmentsJack Cuzick
Lancet (London, England)|May 20, 2014
Radiotherapy for breast cancer, the TARGIT-A trialJack Cuzick
Expert Review of Vaccines|June 2, 2015
Gardasil 9 joins the fight against cervix cancerJack Cuzick
The New England Journal of Medicine|May 5, 2007
Mammographic breast densityJack Cuzick
European Journal of Cancer (Oxford, England : 1990)|September 12, 2008
Hormone replacement therapy and the risk of breast cancerJack Cuzick
Cancer Prevention Research (Philadelphia, Pa.)|June 5, 2010
Long-term follow-up in cancer prevention trials (It ain't over 'til it's over)Jack Cuzick
Gynecologic Oncology|February 5, 2010
Long-term cervical cancer prevention strategies across the globeJack Cuzick
Pageof 42

Showing results (21-30 of 420) with videos related to

Sort By:
Pageof 42
Expert Review of Anticancer Therapy|November 22, 2007
The ATAC trial: the vanguard trial for use of aromatase inhibitors in early breast cancerJack Cuzick
Expert Review of Anticancer Therapy|September 2, 2008
IBIS II: a breast cancer prevention trial in postmenopausal women using the aromatase inhibitor anastrozoleJack Cuzick
Journal of the National Cancer Institute|June 18, 2010
Tamoxifen and the factor V Leiden mutationJack Cuzick
Journal of the National Cancer Institute|November 9, 2014
Endpoints for the evaluation of breast cancer treatmentsJack Cuzick
Lancet (London, England)|May 20, 2014
Radiotherapy for breast cancer, the TARGIT-A trialJack Cuzick
Expert Review of Vaccines|June 2, 2015
Gardasil 9 joins the fight against cervix cancerJack Cuzick
The New England Journal of Medicine|May 5, 2007
Mammographic breast densityJack Cuzick
European Journal of Cancer (Oxford, England : 1990)|September 12, 2008
Hormone replacement therapy and the risk of breast cancerJack Cuzick
Cancer Prevention Research (Philadelphia, Pa.)|June 5, 2010
Long-term follow-up in cancer prevention trials (It ain't over 'til it's over)Jack Cuzick
Gynecologic Oncology|February 5, 2010
Long-term cervical cancer prevention strategies across the globeJack Cuzick
Pageof 42